share_log
Reuters ·  11:50
U.S. FDA Approves Celltrion's Steqeyma® (Ustekinumab-Stba), a Biosimilar to Stelara® (Ustekinumab)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment